Jason Haas - Oct 12, 2021 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role: Chief Financial Officer
Signature: /s/ Jason Haas
Stock symbol: SYRS
Transactions as of: Oct 12, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/13/2021, 04:04 PM
Next filing: Feb 17, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney